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CyclodextrinKV10.1 potassium channels are implicated in a variety of cellular processes including cell proliferation and
tumour progression. Their expression in over 70% of human tumours makes them an attractive diagnostic and
therapeutic target. Although their physiological role in the central nervous system is not yet fully understood,
advances in their precise cell localization will contribute to the understanding of their interactions and function.
We have determined the plasmamembrane (PM) distribution of the KV10.1 protein in an enriched mouse brain
PM fraction and its association with cholesterol- and sphingolipid-rich domains. We show that the KV10.1
channel has two different populations in a 3:2 ratio, one associated to and another excluded from Detergent Re-
sistantMembranes (DRMs). This distribution of KV10.1 in isolated PM is cholesterol- and cytoskeleton-dependent
since alteration of those factors changes the relationship to 1:4. In transfectedHEK-293 cellswith amutant unable
to bind Ca2+/CaM to KV10.1 protein, Kv10.1 distribution in DRM/non-DRM is 1:4. Mean current density was
doubled in the cholesterol-depleted cells, without any noticeable effects on other parameters. These results
demonstrate that recruitment of the KV10.1 channel to the DRM fractions involves its functional regulation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The human ether à-go-go1 protein (Eag1, KV10.1, encoded by
KCNH1) is a voltage-gated potassium channel and is a member of the
EAG family. It is expressed almost exclusively in brain tissue and is in-
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ights reserved.proliferation [4]. The function of KV10.1 in the central nervous system
(CNS) is not yet clear, but its biophysical properties have been studied
in heterologous systems. These properties, including delayed rectifica-
tion and low activation voltage [5], as well as its extreme long cytoplas-
mic regions compared to other non-EAG KV channels [6], and its
expression in highly proliferative tumour tissues suggest that KV10.1
might be involved in non-canonical K+ channel activities. Several intra-
cellular protein interactions, including its regulation by calmodulin [7],
calcium-calmodulin kinase II (CaMKII) [8], rabaptin [9] and cortactin
[10], aswell as its effect on thehypoxia inducible factor (HIF) expression
in heterologous systems [11], imply an involvement with intracellular
signalling processes and with cell cycle-related events [12]. Recently,
the use of imaging techniques indicated that synaptic KV10.1 localises
to the presynaptic membrane [13]; nevertheless, a more detailed de-
scription of its PM localisation at this and other locations is still lacking.
The discovery of different lipid phases-like, known as lipid rafts [14],
within the PM of eukaryotic cells has changed the understanding of
membrane protein dynamics and their interaction with intra- and ex-
tracellular proteins [15–19]. Discrete membrane domain formation is
promoted not only by the lipid composition but also by the specific
localised protein content. The transmembrane protein domains, the
cytoplasmic regions interacting with the cytoskeleton and the co-
expression and interactions with different proteins have also been
shown to participate in the formation of discrete PM domains [20–22].
A higher content of sphingolipids and cholesterol confers to those
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sistance to non-ionic detergent extraction. This property is the basis of
the concept of DRM [25,26]. Functional studies have confirmed that the
lipid compartmentalisation in the PM affects the organisation and func-
tion of proteins involved in several forms of signalling processes. Exam-
ples include the immunological synapse, where the tyrosine kinase Lck
found in lipid rafts is activated by the phosphatase CD45 localised in
non-rafts [17]; the lateral force transmission of skeletal muscle where
the interaction of the membrane protein β-dystroglycan with and the
costameric protein dystrophin is dependent on membrane cholesterol
content in lipid rafts [16]; the neurological synapse, wheremost proteins
of the Soluble NSF Attachment Protein (SNARE) complex have been
shown to be in cholesterol rich domains [27]; and signalling cascades,
in which the human EAG-related gene channel (HERG, member of the
EAG family) localises to caveolae and participates in a transmembrane
signalling complex [15]. In addition to HERG, other voltage-gated ion
channels, including Kv2.1, Kv1.5 and BKCa, are located in PM subdomains,
where their restricted PM localisation influences not only conductance-
related functions but also signalling processes [15,28–30]. Because
KV10.1 is not detected in any other normal tissue but has been described
as amarker inmany tumour tissues [31], the question arises as towheth-
er KV10.1 has different functions within the same cell, depending on its
partitioning in the lipid subdomains of the plasma membrane.
The aim of this study was to examine the subdomain distribution of
the KV10.1-channel in the neural PM isolated from brain tissue as well
as in transfected human embryonic kidney cells. We examined the ef-
fects of partial membrane cholesterol depletion, membrane cytoskele-
ton detachment and Ca2+/CaM binding inhibition on the partitioning
of KV10.1 within the different domains. We also investigated the effect
of MβCD treatment on the K+ currents. We show two different KV10.1
populations in themembrane, one of which is dependent onmembrane
cholesterol concentration, actin submembranal cytoskeleton integrity
and Ca2+/CaM binding.2. Materials and methods
2.1. Experimental models
2.1.1. Mice
All animal experiments were performed in compliance with ap-
proved animal policies of the Max Planck Institute of Experimental
Medicine and the State of Lower Saxony. Adult male wild-type C57BL/
6J mice were used for the isolation of brains.2.1.2. Cells
The HEK-293 cell line was obtained from DSMZ (DSMZ ACC 305,
Germany) and maintained according to the instructions of the supplier.
Stable transfectants with pTracer-KV10.1 [32] and pTracer-KV10.1-BBS
[33] were grown in DMEM/nutrient mixture F-12 with Glutamax-I
(Invitrogen) supplemented with 10% foetal calf serum and selected
with Zeocin (Calya, 0.3 mg/ml in culture medium). Glial cell primary
cultures were obtained from 8 to 10 isolated P0 mice cortices that
were dissected (both hemispheres) and maintained in HEPES–DMEM.
The cells were dissociated by Trypsin–EDTA digestion at 37 °C for
15 min. The isolated cells were washed three times with DMEM and
homogenised through an 18-gauge syringe. The dissociated cells were
collected by centrifugation for 5 min at 500 ×g and resuspended in
fresh DMEM. The cells were maintained in 10 ml flasks for 2 weeks
under standard incubator parameters and then harvested and/or
subcultured when they reached 80–90% confluence. The HEK-293 cells
transiently transfected with the C7-hEag1 mutant (F714S/F717S) were
maintained under the same conditions. The C7 mutant is unable to
bind one Ca2+/CaM molecule in the C-terminal of KV10.1 and shows a
resistance to intracellular calcium inhibition [7].2.2. RT-PCR of glial cells
The RNA from the cultured cells was isolated using RNeasy (Qiagen,
Hilden, Germany) and was reverse transcribed using Super Script
(Invitrogen). Real-time PCR was performed using the TaqMan system
in a Light Cycler Detector as previously described for KV10.1 detection
[31]. For the glial and neuronal markers, primers were selected using
the Universal Probe Library (Roche) and detected with SYBR Green.
2.3. Plasma membrane isolation
The plasma membranes from the brain tissue were isolated using a
modification of the protocol described by Schindler and Nothwang
[34]. Briefly, isolated fresh or frozen (−80 °C) brains were homogenised
with a Teflon pestle homogeniser attached to a drill in Buffer A (15 mM
Tris–HCl, 320 mM sucrose and EDTA-free protease inhibitor, pH7.8) and
centrifuged three times to eliminate nuclei and debris (3000 ×g, 10 min,
4 °C). The supernatant was layered over 850 mMsucrose in Buffer A and
centrifuged for 30 min at 70,000 ×g, at 4 °C. The interface between
320 mM and 850 mM sucrose, which corresponds to myelin cloud
[35], was discarded, and the remaining sample was centrifuged for
30 min at 20,000 ×g, at 4 °C to eliminate the mitochondria and possible
residual myelin. The supernatant was then centrifuged for 1 h at
100,000 ×g at 4 °C to sediment the microsomes. The microsomes were
resuspended in Buffer A with 250 mM sucrose and used for the wheat
germ agglutinin (WGA) binding method of the two-phase affinity sys-
tem as previously described [34]. To evaluate the final product, enzyme
activity assays [36] and Western blotting were performed. The plasma
membranes from the cultured cells were isolated using the protocol de-
scribed by Yao et al. [37].
2.4. Cholesterol depletion and cytoskeleton detachment
Methyl-β-cyclodextrin (MβCD, Sigma-Aldrich) was used to extract
the cholesterol from isolated crude membranes or living cells. The puri-
fied PM from the brain tissue was incubated with 30 mMMβCD for 1 h
at 37 °C with agitation and then washed twice with PBS (pH 7.4). The
pellet of the last wash step underwent the DRM isolation protocol. In
the case of the HEK-KV10.1 cells, the cells were washed with PBS,
trypsinised and divided into 1 ml aliquots of 5–7 million cells each
and then incubated with 10 mM MβCD in serum-free medium for
30 min at 37 °C with agitation. The control samples were treated in
the same manner substituting PBS for the MβCD. The pellets were sub-
sequently frozen at−80 °C or used directly for the PM and DRM isola-
tion procedures.
2.4.1. Actin cytoskeleton detachment
Sodium carbonate (Na2CO3) was used to detach actin from the iso-
lated brain PM. A 500 μl aliquot of PM was incubated with 20 ml of
150 mM Na2CO3 for 5 min on ice and then washed once with PBS. The
pelletwas resuspended in PBS. A 100 μl aliquotwas reserved and the re-
mainder of the sample was incubated with 1% Triton X-100 for isolation
of the DRM. For the HEK-KV10.1 cells, a similar procedure in which 1 μl
of 10 μM Latrunculin A (Lat A, Sigma) dissolved in DMSO replaced the
MβCD. The cells were incubated for 1 h at 37 °Cwith agitation. The con-
trol samples were incubated with 1 μl DMSO alone.
2.5. Isolation of detergent-resistant membrane (DRM)
Unless otherwise specified, the tissue or cell PMwas resuspended
in PBS (pH 7.4), incubated in 1% Triton X-100 for 30 min at 4 °C and
then diluted in an equal volume of an 80% sucrose solution. A discon-
tinuous gradient formed by the addition of 30% and 5% sucrose solu-
tions was then centrifuged for 18 h at 200,000 ×g, at 4 °C. Nine
fractions were recollected from the top to the bottom. The protein
content was determined using the bicinchoninic acid (BCA) protein
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monosialotetrahexosylganglioside (GM1) using a dot-blot. For the
Western blot analysis, the fractions were pooled into three samples:
DRM (fractions 2–4), and non-DRM (fractions 5–6 and 7–9). The
same amount of protein of each pooled sample was precipitated
using trichloroacetic acid (TCA) [38]. The precipitated proteins
were then resuspended in a loading buffer.
2.6. Cholesterol determination
For cholesterol concentration measurement the Cholesterol/
Cholesteryl Ester Quantitation Kit (Biovision) was used according to
the manufacturer's instructions. Absorbance measurements were per-
formed at 570 nm in a 96-well plate. Cholesterol concentration is
expressed in mg cholesterol/mg protein.
2.7. Immunoblotting and densitometry
Protein extracts were separated by gradient SDS-PAGE (either 3–8%
Tris–acetate gel or 4–12% Bis–Tris gel, NuPAGE, Invitrogen) and trans-
ferred to nitrocellulose membranes (Amersham). For dot-blot assays,
3 μl with the same amount of protein concentration of each fraction
was put onto a nitrocellulose membrane and let dry for 15 min. Mem-
branes from either Western blot or dot-blot were blocked at least
30 min with 0.1% casein (Roche Applied Science), 5% non-fat dry milk
(Bio-Rad) or 5% BSA (Sigma) and incubated with the corresponding an-
tibody or toxin. Peroxidase conjugated cholera toxin (1:50,000, Sigma),
O1 pentameric antibody against galactosylceramide (GalCer) (1:50; a
gift from Prof. K.A. Nave, Max-Planck-Institute of Experimental Medi-
cine, Göttingen), Caveolin-1 (Cav-1; 1:300, Polyclonal, Santa Cruz),
Flotillin-2 (Flot-2; 1:1000, monoclonal, BD Bioscience), KV10.1
(1:1500, Polyclonal, 9391; [39]), Transferrin Receptor (TfR; 1:1000,
monoclonal, BD Bioscience), Golgi marker (GM130; 1:500, BD),
Translocon associated protein alpha subunit (TRAPα; 1:1000, Abcam),
Myelin Basic Protein (MBP; 1:1000, Abcam), Proteolipid Protein (PLP,
3F4; 1:250, a gift from Prof. K.A. Nave, Max-Planck-Institute of Experi-
mentalMedicine, Göttingen) and Actin (Abcam; 1:1000). After washing
and incubation with the corresponding peroxidase-labelled secondary
antibody (Invitrogen) if needed, blots were developed using Millipore
Immobilon system. Signals forWestern blot and dot-blot were detected
in a Bio-Rad Chemi-Doc luminescence detection system. Densitometry
analysis was performed with ImageJ.
2.8. Electrophysiology
Cells were grown for 24–72 h on poly-L-lysine-coated glass cover-
slips. For MβCD experiments, cells were incubated in serum-free
medium with 30 mMMβCD at room temperature just before the mea-
surements. Macroscopic currents were recorded in the whole-cell con-
figuration of the patch-clamp technique [40] using an EPC-9 amplifier
(HEKA). Patch pipettes with a tip resistance of 2–5 MΩ were made
from Corning #0010 capillary glass (WPI). Series resistance was
compensated by 70%. Internal solution contained (in mM); 100 KCl,
45 N-Methyl-D-Glutamine, 10 1,1-bis(O-aminophenoxy)ethane-N,
N,N′,N′-tetraacetic acid (BAPTA) tetrapotassium salt, 10 HEPES/HCl,
pH 7.35 and the external solution contained (in mM); 160 NaCl, 2.5
KCl, 2 CaCl2, 1 MgCl2, 8 glucose, 10 HEPES/NaOH, pH 7.4. The holding
potential for all experiments was−70 mV. Electrophysiological exper-
iments were carried out at room temperature. Data processing and
curve fitting were performed with Igor Pro (WaveMetrics). Where
applicable, data are presented as the mean ± standard error.
2.9. Affinity cytochemistry and confocal microscopy
For imaging experiments, HEK-293 stably transfected with pTracer-
KV10.1-BBS was used. Cells were grown on 12 mm fibronectin coatedcoverslips for 48 h and then treatedwith different drugs. For cholesterol
depletion cells were incubated with 5 mMMβCD for 30 min at 37 °C or
with PBS. For actin detachment, incubationwith 1 μMof Lat A or 1 μl/ml
DMSO was performed. After each treatment cells were washed three
times with TBS (pH 7.4), incubated with Cholera Toxin-FITC (CT-FITC,
Sigma, 1 μl/ml) for 5 min at RT, then briefly suspended in TBS and incu-
bated with Bungarotoxin-Alexa Fluor® 555 (BTX-AF555, Invitrogen,
3 μl/ml) for 15 min at RT, washed three times, fixed with 10% formalin
for 10 min at 4 °C, washed 5 times and mounted on slides with
ProLong-DAPI (Molecular Probes). Slides were kept overnight at 4 °C
and were observed in a Leica SP5 confocal microscope. The image anal-
ysis was performed as follows: A Leica SP5 confocal laser-scanning mi-
croscope (CLSM, Leica, Mannheim) equipped with hybrid detectors
was used to record representative fields of view occupied by cells con-
taining the FITC and BTX-AF555 signals. Care was taken to ensure iden-
tical acquisition settings. A macro was generated for the ImageJ
software package “Fiji” [41] and applied to quantify fluorescent signal
originating from the differently treated cells. Herein, a region of interest
(ROI) was drawn manually for each cell, which delineated the lower,
planar cell membrane, but excluded cell edges, where the membrane
curls upward and ismore difficult to quantify due to out-of-focus signal.
A binary image of the respective FITC and BTX-AF555 channelswas gen-
erated by applying the “MidGrey” local thresholdingmethod with a 15-
pixel radius [41]. The binary images were then added to generate an
image in which the area covered by the overlapping signals could be
measured and normalised to the overall ROI area in order to obtain
the percent overlapping area. The means were then calculated from
91 CTRL and 92 MβCD-treated cells.
2.10. Statistical analysis
For the statistical analysis we used Excel and StatPlus. For all densi-
tometric and microscopy image analyses ImageJ programme was used
and a non-paired two-tailed t test was performed. In the case of current
recording, analysis was performedwith the Igor programme and a non-
paired one-tailed t test was used.
3. Results
3.1. Purified plasma membranes
Plasma membranes from brain tissue were isolated using a modifi-
cation of a previously described differential centrifugation and a discon-
tinuous sucrose gradient procedure [34]. The major modification was
the addition of a sequential centrifugation step for myelin extraction
based on classical isolation methods [42]. Fig. 1 shows the characterisa-
tion of the isolated PM. Fig. 1A shows a dot blot for GalCer in the isolated
PM compared with the initial homogenate, where only 50% of GalCer
was removed. However, after myelin extraction, 94% of the GalCer was
removed. Fig. 1B shows that the content of the two major myelin pro-
teins, MBP and PLP, diminished by 35% and 37%, respectively, in the iso-
lated PM relative to the initial homogenate. To further analyse thepurity
of the final PM fraction, assays of the three major membrane enzymes
selective for intracellular membrane sources were performed. Fig. 1C
shows that the Relative Specific Activity (RSA) of alkaline phosphatase
increased 5-fold in the PM fraction compared with the initial homoge-
nate. The RSA of succinate dehydrogenase was 0.19 ± 0.36 and for
NADPH cytochrome c reductase was 0.47 ± 0.08; the RSA was less
than one in both cases. Fig. 1D showsWestern blots for GM130, a mark-
er for the Golgi membranes, and TRAPα, a marker for the endoplasmic
reticulum, in the different membrane fractions. GM130 was absent
from the PM fraction, and the TRAPα content in this fraction was re-
duced to 5% of the signal observed in the initial homogenate. Further
analysis of the KV10.1 membrane distribution was performed in an
enriched PM fraction with minimal or no contribution from myelin
and inner membranes.
Fig. 1. Characterization of PM fractions isolated from the brain. A) Dot-blot against GalCer
in fractions obtainedwith the original protocol (withoutmyelin extraction) and ourmod-
ified protocol (withmyelin extraction); H: total homogenate, M:microsomes, PM: Plasma
membrane fraction. B)Western blot detection of two of the main myelin protein markers
MBP (Myelin Binding Protein) and PLP (Proteolipid Protein). C) Enzyme activity assays,
expressed as the PM relative activity compared to the total homogenate; AP: Alkaline
Phosphatase (PM marker; n = 10, mean ± SD = 4.47 ± 4.47), SD: Succinate Dehydro-
genase (mitochondriamarker; n=6, 0.48 ± 0.37), NADPHCcR: NADPHCytochrome c Re-
ductase (endoplasmic reticulummarker; n = 5; 0.43 ± 0.08). D)Western blot detection
of the Golgi protein GM130 and the reticulum protein TRAPα in the different membrane
fractions.
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Neuronal KV10.1 expression has been widely described [43,44];
however, KV10.1 expression in glia has not previously been studied.
Fig. 2 shows the normalised value of the RT-PCR analysis performed
for mouse glia and neuron markers in three different cell cultures. The
marker for astrocytes was Glial fibrillary acidic protein (Gfap); for
microglia, Allograft inflammatory factor-1 (Alf1); for oligodendrocytes,
Oligodendrocyte transcription factor-2 (Olig2); and for neurons,
Microtubule-associated protein (Mtap1) and synaptophysin (Syn). The
results showed in three independent cultures of different passages
and different distributions of glia cell types, only traces of neuronal
RNA could be detected, and the KV10.1 message was virtually absent
(0.012 ± 0.03). These results allow us to interpret the subsequent
results as essentially specific to neurons.Fig. 2. Characterization of primarymouse glia cell cultures, KV10.1 is not expressed by glia
cells. RT-PCR in three separate cultures enriched in different glia cells. Normalized RNA
content with TfR for three different glia markers (mGfap, mAlf1 and mOlig2), two neuron
markers (mMtap2 and mSyp) and mKV10.1.3.3. Lipid and protein distribution in isolated neuronal plasma membrane
from brain tissue
From the purified PM, the DRMs were isolated and characterised.
Fig. 3A shows a dot-blot for the ganglioside GM1, which was primarily
present in fractions F3 and F4 and absent in fractions F8 and F9. Regard-
ing the specific protein content of the DRM and non-DRM fractions,
Fig. 3B shows that TfR was exclusively detected in the non-DRM frac-
tions, while Cav-1 and Flot-2 preferentially localised in the DRM. In
the case of KV10.1, 61% (n = 8) was found in the DRM and the rest in
the non-DRM. Fig. 3C shows the protein and cholesterol concentrations
of four representative fractions, two corresponding to the DRM (3 and
4) and two to the non-DRM fraction (8 and 9). The DRM fractions
accounted only for 9% of the total PM protein concentration, whereas
the cholesterol content was 3 times higher in F3 than in the total PM:
F3 contained 1.279 ± 0.43 mg chol/mg prot. In contrast, the non-
DRM fractions contained 71% of the total protein and a lower cholesterol
concentration (fraction 9, 0.167 ± 0.06 mg chol/mg prot). Therefore,
there were at least two different populations of KV10.1 within the neu-
ronal PM, one that partitioned into the DRM subdomain of the PM,
enriched in GM1, cholesterol, Cav-1 and Flot-2, and another population
that was not associated with the DRM. Co-immunoprecipitation assays
to test for a possible physical interaction between Cav-1 and DRM-
KV10.1 were negative (data not shown).
3.4. Neuronal PM-DRM KV10.1 localisation is dependent on the cholesterol
concentration and the integrity of submembrane cytoskeleton
To investigate the factors that determine the distribution of KV10.1
in the cholesterol-enriched PM subdomains, we isolated DRM from
PM previously incubated with 30 mMMβCD to deplete the cholesterol.
Fig. 4A–D shows the PM and DRM characterisation after cholesterol de-
pletion. Fig. 4A shows that the MβCD treatment reduced the total PM
cholesterol content by 81%; however, this procedure did not substan-
tially alter the GM1 distribution between DRM and non-DRM fractions
(Fig. 4B). In terms of protein distribution, the MβCD treatment reduced
the content of Cav-1 and Flot-2 in the DRM fractions and increased their
concentrations in the non-DRM fractions (Fig. 4C). The extraction of
cholesterol with MβCD reduced the cholesterol concentration in the
DRM from 1.279 ± 0.43 to 0.100 ± 0.09 mg cholesterol/mg protein
in F3, but the concentration in non-DRM fractions was not changed
(Fig. 4D). Because DRM proteins such as Cav-1 and Flot-2 interact
with the submembrane cytoskeleton proteins in other systems [16],
we investigated the importance of the submembrane cytoskeleton in-
tegrity on the DRM lipid and protein composition. Fig. 4E–H shows
the effect of a basic pH shock with 150 mM Na2CO3 (pH 11) on the
DRM lipid and protein composition. After the Na2CO3 treatment, the
PM-associated actin was reduced by 88% (Fig. 4E); the inset in Fig. 4E
shows a Western blot of a representative experiment in which TfR
was used as an internal control. After the pH shock, GM1 was evenly
distributed among the DRM and non-DRM fractions (Fig. 4F). This
treatment also caused loss of the signals for Cav-1 and Flot-2 in
the DRM fractions and for TfR in the non-DRM fractions (Fig. 4G).
As shown in Fig. 4H, cholesterol concentration in the DRM
(0.819 ± 0.369 mg chol/mg prot) and the non-DRM (1.095 ±
0.570 mg chol/mg prot) fractions was similar to the concentration
in the PM (0.638 ± 0.230 mg chol/mg prot).
Because MβCD and Na2CO3 modified the DRM lipid and protein
composition, the KV10.1 distribution was studied following treatment
with these agents. Fig. 5A shows a representative Western blot with
an anti-KV10.1 antibody showing changes in the distribution of KV10.1
in the DRM and non-DRM fractions. Densitometric quantification of
the DRM-KV10.1/non-DRM-KV10.1 ratio is shown in Fig. 5B. Under the
control conditions, the average ratio was 1.74 ± 0.644 (n = 8). This
ratio was significantly reduced by both cholesterol depletion (ratio
0.175 ± 0.130; n = 6) and actin detachment (0.153 ± 0.105; n = 3)
Fig. 3.Characterization of DRM isolated frombrain PM, KV10.1 associateswith DRM. A)Dot- blot against GM1 ganglioside in the 9 fractions of the sucrose gradient. DRM are constituted by
fractions 2–4. Non-DRM from fractions 5–9were divided into two: 5–7 and 8,9. B) Distribution of KV10.1 in themembrane fractions; 60% of KV10.1 expresses in DRM fractionswhere two
other raft markers are also present (flot-2 and cav-1), the other 40% is found in the lowest non-DRM fraction together with the non-raft marker TfR (n=8). C) Protein concentrations in
mg/ml (white columns) of four representative fractions (n=9): DRM (Fr:3, 0.11 ± 0.05; Fr:4, 0.06 ± 0.03) and non-DRM (Fr:8, 0.31 ± 0.16; Fr:9, 1.11 ± 0.53) and cholesterol concen-
tration in mg Chol/mg Prot (black columns) of the same fractions (n=12): DRM (Fr:3, 1.28 ± 0.44; Fr:4, 0.39 ± 0.31) and non-DRM (Fr:8, 0.5 ± 0.19; Fr:9, 0.17 ± 0.06).
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relocates from the DRM fraction to the non-DRM fraction after MβCD
and Na2CO3 treatments. To evaluate the degree of relocation of the
DRM-associated KV10.1 with respect to other DRM- and non-DRM-
resident proteins, we calculated the ratios of KV10.1/Flot-2 and
KV10.1/TfR (Fig. 5C). For the control DRM fractions, the KV10.1/Flot-2
ratio was 0.697 ± 0.205, and in the non-DRM fractions, the KV10.1/
TfR ratio was 0.433 ± 0.150, in good agreement with the DRM-
KV10.1/non-DRM-KV10.1 ratio of 3:2. For theMβCD treatedmembranes
we observed a KV10.1/Flot-2 ratio of 0.155 ± 0.119 in the DRM frac-
tions and a KV10.1/TfR ratio of 0.9 ± 0.087 for the non-DRM fractions.
This result suggests that cholesterol depletion with MβCD has a greater
effect on the DRM-associated KV10.1 than it does on Flot-2. After the re-
moval of the submembranal cytoskeleton with Na2CO3, we observed a
KV10.1/Flot-2 ratio of 1.827 ± 0.561 for the DRM fractions and a
KV10.1/TfR ratio of 0.939 ± 0.016 for the non-DRM fractions. Thus,
our results show that the submembrane cytoskeleton is needed for
proper PM protein partitioning of both KV10.1 and Flot-2. The effect of
the detachment of the submembrane cytoskeletal proteins on KV10.1
PM partitioning was stronger than the effect of cholesterol depletion.These results indicate that both cholesterol and the submembrane cyto-
skeleton are key factors determining the K+ channel distribution in the
two populations.
3.5. KV10.1 localisation in HEK cells is dependent on
cholesterol concentration
The effects of MβCD on KV10.1 membrane distribution in cultured
HEK cells can be seen in Fig. 6. Fig. 6A shows a Western blot for
KV10.1 in the DRM and non-DRM fractions after cholesterol depletion
with 10 mM MβCD compared to the control. Fig. 6B shows the DRM-
KV10.1/non-DRM KV10.1 ratios for the control membranes incubated
with PBS and the ratio of 0.789 ± 0.382 was compatible with a 2:3
ratio. After cholesterol depletion, the DRM-KV10.1/non-DRM-KV10.1
ratio decreased by 58% to 0.330 ± 0.220 (p b 0.01). These results,
obtained from a cultured cell system, confirm that the cholesterol con-
centration in the PM is essential for KV10.1 partitioning into the
cholesterol-enriched membrane domains. When the cytoskeleton in-
tegrity was altered, we also observed a tendency to decrease the
amount of KV10.1 in the DRM domains, although the difference was
Fig. 4. Brain DRM characterization after cholesterol depletionwithMβCD (A–D) and after actin cytoskeleton detachmentwith Na2CO3 (E–H). A) Cholesterol (mg/mg Prot) depletion after
1 h incubationwith 30 mMofMβCD. 81% of the inicial amount was extracted from the isolated PM (n = 8, control: 0.462 ± 0.1, MβCD: 0.09 ± 0.01, p b 0.01). B) Dot-blot against GM1.
C) WB showing the distribution of the three domains markers flot-2, cav-1 and TfR in the different fractions. D) Protein concentrations in mg/ml (white columns) of four representative
fractions (n=7): DRM (Fr:3, 0.07 ± 0.05; Fr:4, 0.09 ± 0.07) and non-DRM (Fr:8, 0.4 ± 0.18; Fr:9, 0.99 ± 0.56) and cholesterol concentration inmg chol/mg prot (black columns) of the
same fractions (n=8): DRM (Fr:3, 0.1 ± 0.08; Fr:4, 0.02 ± 0.02) and non-DRM (Fr:8, 0.29 ± 0.13; Fr:9, 0.14 ± 0.07). E) Densitometric analysis of actin detachment (normalized with
TfR). Actin decreased in 88%. (n = 5, control: 1.69 ± 0.61, natrium carbonate: 0.21 ± 0.21, pb0.05). Inset: Representative Western blot of isolated PM after treatment with 150 mM
of Na2CO3; TfR was used as control. F) Dot-blot against GM1. G)WB showing the distribution of the three domain markers flot-2, cav-1 and TfR in the different fractions. H) Protein con-
centrations inmg/ml (white columns) of four representative fractions (n = 3): DRM (Fr:3, 0.13 ± 0.09; Fr:4, 0.15 ± 0.1) and non-DRM(Fr:8, 0.29 ± 0.08; Fr:9, 0.53 ± 0.29) and choles-
terol concentration in mg Chol/mg Prot (black columns) of the same fractions (n=8): DRM (Fr:3, 0.82 ± 0.37; Fr:4, 0.34 ± 0.15) and non-DRM (Fr:8, 1.1 ± 0.57; Fr:9, 0.5 ± 0.2).
926 A.M. Jiménez-Garduño et al. / Biochimica et Biophysica Acta 1838 (2014) 921–931not statistically significant (data not shown). To further investigate the
effect of MβCD on the HEK-KV10.1 cells, we performed confocal micros-
copy experiments. Fig. 6C shows representative images of the co-
localisation of KV10.1 (red) and CTX (green) after the MβCD treatment.
The statistical analysis is shown in Fig. 6D; a significant decrease in the
percent of co-localisation is observed after the MβCD treatment
(p b 0.001). In the case of Lat A treatment, the overlapping area showed
a significant increase (data not showed). In contrast to the brain mem-
branes, the cytoskeleton does not appear to play a key role in the KV10.1
membrane distribution in the HEK-KV10.1 cells. We therefore investi-
gated whether other factors could be contributing to the partitioning
of these channels in the PM of the HEK-KV10.1 cells.
3.6. Ca2+/CaM binding modulates Eag1 DRM partitioning in
HEK-KV10.1 cells
We transiently transfected HEK-293 cells with the C7 mutant (see
Materials and methods) and isolated the DRM. Fig. 8A and B shows im-
ages of a representativeWestern blot and the plotted ratios, respectively.
A reduction in the DRM-associated KV10.1 is observed, reflected by thedecrease of the DRM-KV10.1/non-DRM-KV10.1 ratio to 0.233 ± 0.083
(p b 0.01). This result strongly suggests that Ca2+/CaM is also a contrib-
uting factor for the KV10.1 partitioning to the raft domains, where
presumably the negative current modulation occurs.
3.7. KV10.1 currents in HEK cells increase after MβCD treatment
To determine the functional correlate of cholesterol depletion, we
measured KV10.1 currents in whole-cell patch clamp experiments be-
fore and after MβCD incubation (Fig. 7). After cholesterol extraction,
the current density in response to a depolarisation to +60 mV in-
creased by approximately two-fold, from 262.4 ± 25.1 pA/pF (n = 7)
to 489.8 ± 79.37 pA/pF (n = 7, p b 0.05); representative recordings
are shown in Fig. 7A and B. In the current–voltage relationship shown
in Fig. 7C, it can be appreciated that the increase was already significant
in the range from +20 mV to +80 mV. Because the activation time
constant of KV10.1 shows a characteristic dependence on pre-pulse po-
tential [45], we also measured the 20–80% rise time of currents elicited
by a depolarisation to+40 mVafter 5 s prepulses to−120 or−60 mV.
Cholesterol extraction did not affect the time required for the channel to
Fig. 5. Brain KV10.1 membrane distribution is affected by cholesterol depletion and actin
cytoskelton disturbance. A) Western blot against KV10.1 in the different fractions after
treatment with MβCD and Na2CO3. B) KV10.1 ratio between the amount of KV10.1 in
DRM divided by the amount in KV10.1-non-DRM in control (n = 8, 1.74 ± 0.64) and
MβCD (n = 6, 0.18 ± 0.13) and Na2CO3 (n = 3, 0.15 ± 0.1) treated membranes. C)
KV10.1 percentage normalized with the loading control of each fraction. For DRM the per-
centage of flotilin was used (control: n=4, 0.7 ± 0.2; mβcd: n = 5, 0.15β0.12; Na2CO3:
n=3, 1.83 ± 0.56), for non-DRM TfR percentage was used. (control: n = 4,
0.43 ± 0.15; mβcd: n = 5, 0.9 ± 0.08; sodium carbonate: n = 3, 0.94 ± 0.03).
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[46], suggest that cytoskeleton integrity and cholesterol concentration
participate as stabilising factors for KV10.1 currents. Specifically, when
these factors are disturbed, the currents increase.
4. Discussion
In the present study, we demonstrate that 1) KV10.1 is expressed in
neural but not in glial cells ofmice; 2) two populations of KV10.1 partition
into differentmembrane domains; 3) partitioning to theDRMdepends on
cholesterol, the cytoskeleton and Ca2+/CaM; and 4) cholesterol depletion
increases KV10.1 K+ current density in HEK-KV10.1 cells.
4.1. KV10.1 is expressed in neural cells
The expression of KV10.1 in neurons has been demonstrated using in
situ hybridisation and immunohistochemistry, but expression in glial
cells has not been specifically addressed [13,43,44]. We did not observeexpression of KV10.1 in cultured mouse glia cells. This result is specifi-
cally interesting because over 50% of human gliomas express KV10.1
[47]. Thus, the presence of KV10.1 appears to be an abnormal acquired
expression in gliomas, as it is in other solid tumours [31].
4.2. Partitioning of KV10.1 in plasma membrane subdomains
Several proteins, such as caveolins, flotillins, Src, Lck, Rab11, H-Ras,
dystroglycans, BK channels, HERG, Kv1.5, Kv1.4 and Kv4.3 are known
to associate with detergent-resistant membrane domains enriched in
cholesterol and sphingolipids, while other transmembrane proteins
such as TfR, calnexin,Na+/K+ATPase, K-ras, KV3.2 andKV4.2 are exclud-
ed from these membrane domains [19,29,48–59]. Our results indicate
that the KV10.1 present in PM isolated from neurons distributes
between the DRM and non-DRM fractions, suggesting the existence of
at least two populations of the protein with respect to their affinity to
interact with specific lipids and proteins. Whether KV10.1 partitioning
into the DRM is a stable or a transient state needs to be further investi-
gated. KV10.1 thus belongs to the group of K-channels, such as Kir2 [60],
KV2.1 [55] and KV4.1 [56], that have also been shown to partition to the
DRM aswell as to the non-DRM domains. In order to reside in the DRM,
the length of a transmembrane segment must match the thickness
of the cholesterol-enriched membranes [61–63]. This depends on pro-
tein sequence, but changes in protein conformation can also induce
mismatching with membrane thickness and therefore result in exclu-
sion. Such conformational changes can be an effect of protein–protein
and protein–lipid interactions. For example, the kinase PKC-βII associ-
ates with DRM, depending on the co-expression of the protein ZAP70
in leukaemia cells [22]. The Low Density Lipoprotein Receptor 1 (LPR-
1) resides in thenon-DRMdomains in culturedfibroblasts and epithelial
cells but is present in the DRM isolated from a smooth muscle cell line
[64]. This evidence indicates that the distribution process of membrane
proteins involves a more complex regulation than the amino acid
sequence alone. The factors involved in this regulation could include
post-translational events (phosphorylation and glycosylation), pro-
tein–protein interactions within membrane domains, as the case of
CD45 and Lck associationswithin the immunological synapse [17] or in-
teractions betweenmembrane proteins and cytoskeletal proteins as has
been shown for the transmission of the lateral force between β-
dystroglycan and dystrophin in skeletal muscle [16]. In any case, differ-
entmembrane distributions of a protein are incompatible with identical
structures and conformations.
4.3. KV10.1 PM distribution is dependent on cholesterol, cytoskeleton
integrity and Ca2+/CaM binding
Cholesterol extraction with MβCD revealed a close relationship be-
tween the concentration of this lipid and DRM/non-DRM partitioning
of KV10.1 in brain and HEK cells. Although MβCD has a direct effect on
cholesterol and an indirect effect on glycolipids (GM1) and proteins,
there are reports that demonstrate that a fraction of the sphingolipid
core domain remains buoyant after cholesterol depletion [65]. We ob-
served the same effect in our experiments (Fig. 5B), in which isolation
of GM1-rich fractions was still possible despite the extraction of mem-
brane cholesterol. There are several examples that demonstrate that
the extraction of cholesterol with MβCD varies widely among mem-
brane proteins and cell systems. Our results show that 30 mM MβCD
reduces the cholesterol content in isolated neural PM by 80%, but only
10 mM of MβCD is required to obtain the same effect in cultured
HEK-KV10.1 cells. In other tissues, including the skeletal muscle, a
10 mM concentration of the same compound reduces the membrane
cholesterol by only 12% but has a large effect on muscle contractility
[16]. Furthermore, different proteins may behave differently after
MβCD treatment. For example, some proteins such as Lck dissociate
completely from the DRM after cholesterol depletion, while others, in-
cluding the antigen Thy-1 [65] and Flot-2, dissociate only partially
Fig. 6. KV10.1membrane distribution is affected by cholesterol depletion in HEK-KV10.1 cells. A)Western blot against KV10.1 in the fractions of isolated PM from HEK- KV10.1 after treat-
ment with PBS or 10mMMβCD. B) KV10.1 ratio between KV10.1-DRM and the KV10.1-non-DRM of control and treated membranes (n = 6, p b 0.01). C and E) Merged confocal micros-
copy images of HEK-BBS-KV10.1 cellsmarkedwith bungarotoxin-AlexaFluorâ 555 for KV10.1 signal (red) andCT-FITC for GM1 signal (green), treatedwith PBS or 5 mMofMβCD; scalebar:
10 μm; Inset: Single channel images for each staining. D and F) Binary masks indicating the location of either single-stained BTX-AF555 (red) or GM1 (green) pixels, as well as areas in
which both stains are present (yellow). G) Comparison of the percent overlapping area between Kv10.1 and GM1 treated with either PBS (control, n = 91) or MβCD (n = 92) in cells
originating from three different experiments (p b 0.0001).
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that KV10.1 belongs to the second group. Because no direct interaction
of KV10.1 with cav-1 was found, it seemed unlikely that cholesterol
alone determined the location of KV10.1 at DRM; therefore, we looked
for additional regulating factors.
Although it was not evident when the first lipid raft model was pro-
posed [66], it is now accepted that in addition to the lipid content, the
proteins associated with the PM are important for stabilising the do-
main structures. Actin is the key regulator for clustering the proteins
in “islands” independent of the lipid content [67]; thus, the PM-bound
cytoskeleton and transmembrane protein pickets form fences dividing
the cell surface into compartments of 40–300 nm [68]. Experiments
with Lat A andCytochalasin B indicate that the actinmeshwork integrity
is important for the association of certain proteins including acetylcho-
line receptors and anion, calcium, and potassium channels with the
DRM [69–72]. In our study, the use of Na2CO3 removed almost 90% of
the attached actin from the brain tissue PM. We show that in the
absence of the underlying protein structure, neuronal membranes
lose their original organisation (Fig. 5E–H), domains are drastically
disrupted and their detergent resistance is altered. These results are in
good agreement with the mesoscale membrane model, which states
that the cytoskeleton-defined compartments are the highest hierarchi-
cal level of the PM in determining and limiting the behaviour of the lipid
phases [68]. However, the role of the cytoskeleton integrity in the asso-
ciation of KV10.1 with the DRM in the HEK cells appears to be different;
both biochemical and confocal microscopy results strongly indicate that
the association of KV10.1 with the DRM remains, despite the effects of
Lat A on actin polymerisation. Such disparities could be attributed tothe differences in the cytoskeleton structure of the two types of cells.
In support to this concept, radixin, a protein that connects the α5-
GABAA receptor to the actin cytoskeleton in brain tissue, does not inter-
actwith the receptorwhen analysed inHEK-293 transfected cells [73]. It
has been reported that the targeting of the alpha 2c adrenoreceptor
depended not only on the cell type but also on the differentiation
state of a neuroendocrine cell line [74]. The different interactions be-
tween KV10.1 and the cytoskeletal proteins that might be taking place
in neurons compared to the HEK-KV10.1 cells could account for the dif-
ferences observed in the channel dependence on actin integrity for DRM
association.
Finally, we asked whether another factor besides cholesterol could
contribute to KV10.1 PM partitioning in HEK-KV10.1 cells. Both the N-
and the C-terminal domains of KV10.1 have very well defined binding
sites for Ca2+/CaM and a mutant channel (C7) resistant to the Ca2+-
CaM binding effect has already been described [7,75]. We analysed the
PM partitioning of KV10.1 when the C7 mutant was transfected to
HEK-293 cells, and we observed a reduction in the DRM-associated
KV10.1 (Fig. 8). Although this is the first report where the binding of
Ca2+/CaM is explicitly tested as a determining factor for a raft-protein
association, a closer examination into the literature provides additional
evidence indicating that this can be a general feature of CaM-binding
proteins. Du and co-workers reported that association of CaMKII mu-
tants lacking the CaM binding site (291–301) to raft domains was par-
tial or absent [76], compared to the behaviour of wild-type CaMKII
[77]. Similarly, only the Ca2+-sensitive adenylyl cyclases partition to
membrane rafts, and the cytosolic domains (CaM binding sites) and
not the transmembrane spans are responsible for their partitioning
Fig. 7.KV10.1 density current increases afterMβCD treatment. Representativewhole cell recordings inHEK- KV10.1 cells A) control and B) in 30 mMMβCD. C) Graphical representation of
the current density at different depolarizing stimuli; from+20 mV to +80 mV the increase is statistically significant (p b 0.05, n = 7). D) Time to rise of control and treated cells after a
500 ms hyperpolarization pre-pulse and a depolaritzation to +40 mV; no difference in the opening time is observed after cholesterol depletion.
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the regulation of the localisation of some lipid raft proteins. However,
calcium is able to bind to the membrane and diminish the flip-flop
rate of lipids, a condition that supports the gel state [78]. Furthermore,
it has been demonstrated that an increase in the intracellular Ca2+ is a
contributing, but not necessary, factor for changes in the phospholipid
content of leukaemia cells [79]. Togetherwith our results, these findings
suggest that Ca2+ and/or Ca2+/CaM could play a role in the regulation
of some protein or lipid partitioning within the PM. The fact that Ca2+
channels and many Ca2+-regulating proteins such as calsequestrin,
calreticulin and Ca2+ pumps reside inside these domains [21,71,80]
could explain the tight regulation of the Ca2+ concentrations in those
localised regions of the membrane.
4.4. Cholesterol-dependent K+-current density in HEK-KV10.1 cells
After cholesterol depletion with MβCD, the current density of HEK-
KV10.1 cells increases significantly (Fig. 8A and B).We also demonstrate
that the disruption of cytoskeleton through the inhibition of actinFig. 8.DRMdistribution of the C7KV10.1mutant inHEK-293 cells. A)Western blot against
KV10.1 in HEK- KV10.1 and HEK-C7 cells after DRM isolation. B) KV10.1 ratio between the
amount of KV10.1 in DRM and the amount in KV10.1-non-DRM in control (n = 9,
0.79 ± 0.13) and C7 (n = 4, 0.23 ± 0.04, p b 0.01) cells.polymerisation is associated with a delocalisation of GM1, KV10.1, flot-
2 and cav-1 from the DRM domains. Disturbance of actin cytoskeleton
with cytochalasin B also increases the current density of KV10.1-
transfected CHO cells [46]. One interpretation of these observations is
that perturbations of the membrane structure by either cholesterol de-
pletion or cytoskeleton-disrupting agents induce an increase in current
due to dissociation of the KV10.1 protein from the DRM. If this is the
case, the DRM-associated KV10.1, which accounts for approximately
60% of all PMKV10.1,would not contribute to the total current recorded,
and DRM domains would constitute a discrete domain where KV10.1
might be stored or exert a different DRM-related function. This behav-
iour is shared by other channels, for example HERG, KV1.5, BK and
CaV2.2 [57,71,81,82]. KV2.1 channels are organised into clusters (“cor-
rals”) where they do not contribute to the whole cell current [83]. In
general, changes in lipids and anchoring of proteins can influence the
electromechanical properties of channels. In the case of the nicotinic
acetylcholine receptor [84], changes in the fatty acid and steroid content
of the membrane are responsible for the transition between the resting
and desensitised states. Direct contact between the lipids and trans-
membrane regions of this receptor has been described, and the mem-
brane is proposed as a key player for the fine-tuning of the channel
activity within specific submembrane domains [85].5. Conclusion
In isolated PM from neuronal tissue, KV10.1 is segregated into two
different populations, one associated with the DRM and dependent on
the PM cholesterol and on the actin–cytoskeleton and to Ca2+/CaM in
PM from transfected HEK-293 cells, with a mutant unable to bind
Ca2+/CaM to Kv10.1 protein, and another associated with non-DRM
fraction. The partition of KV10.1 to the different PM DRM/non-DRM
seems to play a role in the regulation of its conductive properties as it
is dependent on cholesterol in PM of living cells.
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